Analysts Viewpoint
Analyzing Denali Therapeutics Inc (DNLI) After Recent Trading Activity
In a filing, Denali Therapeutics Inc revealed its President and CEO Watts Ryan J. unloaded Company’s shares for reported $7.43
Menu
In a filing, Denali Therapeutics Inc revealed its President and CEO Watts Ryan J. unloaded Company’s shares for reported $7.43
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Denali Therapeutics
Denali Therapeutics Inc’s recently made public that its President and CEO Watts Ryan J. unloaded Company’s shares for reported $7.43
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Denali Therapeutics Inc revealed its President and CEO Watts Ryan J. unloaded Company’s shares for reported $7.43
Denali Therapeutics Inc’s recent filing unveils that its Chief Medical Officer Ho Carole unloaded Company’s shares for reported $0.25 million
Denali Therapeutics Inc. (NASDAQ:DNLI) does about 640.18K shares in volume on a normal day but saw 472397 shares change hands